Comparison
13q Partial Monosomy Syndrome C0265451 vs 17 20 Lyase Deficiency Isolated Included CN372394
Clinical comparison between 13q Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated Included CN372394 for differential diagnosis and treatment planning.
13q Partial Monosomy Syndrome C0265451
A rare genetic condition involving deletion of material from chromosome 13. It can lead to developmental delays, growth concerns, and various physical features. Treatment involves supportive care addressing each individual's specific challenges.
17 20 Lyase Deficiency Isolated Included CN372394
6 comparison axes
Onset
13q Partial Monosomy Syndrome C0265451
0-null
17 20 Lyase Deficiency Isolated Included CN372394
0-16
Onset patterns differ
Severity
13q Partial Monosomy Syndrome C0265451
severe
17 20 Lyase Deficiency Isolated Included CN372394
severe
Different severity levels
Chronic
13q Partial Monosomy Syndrome C0265451
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
Differing course
Communicable
13q Partial Monosomy Syndrome C0265451
No
17 20 Lyase Deficiency Isolated Included CN372394
No
Different transmission
Body System
13q Partial Monosomy Syndrome C0265451
congenital
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Same/different system
Category
13q Partial Monosomy Syndrome C0265451
genetic
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Different category
Bottom line
13q-partial-monosomy-syndrome-C0265451 and 17-20-lyase-deficiency-isolated-included-CN372394 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 13q Partial Monosomy Syndrome C0265451 | 17 20 Lyase Deficiency Isolated Included CN372394 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Congenital developmental delay and growth concerns may occur. | The main concern is sex-steroid production, not a chromosomal developmental syndrome. | High |
| Pubertal or genital findings | Not identified as defining in the supplied description. | Undervirilization or delayed puberty may occur, but the exact pattern is not established here. | Moderate |
| Multisystem congenital features | Variable physical features may accompany the deletion. | Findings center on endocrine steroid synthesis rather than a deletion syndrome. | High |
When to favor each condition
Choose 13q Partial Monosomy Syndrome C0265451 when
Congenital anomalies with developmental delay
Chromosomal evaluation is more relevant than steroid enzyme testing.
High
Suspected or known chromosome 13 deletion
Confirmation depends on cytogenetic or genomic testing.
High
Planning individualized supportive care
Care addresses specific developmental and physical challenges rather than enzyme replacement.
Moderate
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
Disordered sex development or delayed puberty
Isolated lyase deficiency belongs in the endocrine differential when no chromosomal explanation is found.
Moderate
Steroid pattern suggesting reduced sex steroids
Specialist correlation may support impaired sex-steroid synthesis; no cutoff is supplied here.
Moderate
Variant affecting CYP17A1 lyase activity
Molecular results may support the diagnosis only with clinical correlation.
Low
How key tests differ
| Test | 13q Partial Monosomy Syndrome C0265451 | 17 20 Lyase Deficiency Isolated Included CN372394 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | May show partial monosomy of 13q. | Not expected to establish isolated lyase deficiency. | A deletion supports the left diagnosis; a normal result does not exclude the right condition. |
| Specialist steroid profile | Not a primary diagnostic test in the supplied data. | May suggest impaired androgen or estrogen synthesis; cutoffs are not established here. | An abnormal profile is a finding, not a diagnosis by itself. |
| CYP17A1 or targeted genetic testing | Not the defining test for the deletion syndrome. | A relevant variant may support isolated lyase deficiency. | Variant significance requires genetics and endocrine interpretation. |
Prognosis comparison
13q Partial Monosomy Syndrome C0265451
- Outcome
- Often chronic and potentially severe, although individual outcome varies and is not quantified.
- Factors
- Deletion extent, associated anomalies, and developmental support.
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- A chronic endocrine condition whose long-term outcome is not established from the supplied data.
- Factors
- Degree of sex-steroid deficiency, timing of recognition, and specialist care.
Time frame: Both may require lifelong follow-up; the exact course is not established.
Confirmed diagnosis, associated findings, and access to appropriate supportive or endocrine care.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Possible and variable. Not established as a core feature from the supplied data. Cognitive outcome should not be assumed for either condition. |
| Growth impairment | Growth concerns are described. A growth effect is not established in the supplied source. Growth should be monitored individually. |
| Sex-steroid deficiency effects | Not the defining complication. Pubertal delay, fertility concerns, or bone-health effects may occur; specifics are not established. Endocrine follow-up is appropriate when this condition is suspected. |
Patient education highlights
- HighDifferent causes
One condition is a chromosome deletion; the other is a rare enzyme disorder. They are not interchangeable diagnoses.
- HighMeaning of tests
An abnormal chromosome or hormone result needs specialist confirmation and is not a complete diagnosis alone.
- MediumIndividual care
Management and outlook depend on confirmed findings. Doses and exact outcomes are not specified here.